This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
AHCPR Teams with NCPIE to Help Consumers Follow Prescription Medicine Treatment Plans
Press Release Date: August 24, 1995
The Agency for Health Care Policy and Research and the National
Council on Patient Information
and Education have announced a partnership to help consumers
understand the importance of
following prescription medicine treatment plans.
"AHCPR and NCPIE are creating a new consumer publication on
compliance to encourage safe and effective use of prescription
medicines and help consumers
work closely with their physicians, pharmacists and other health
care providers in planning and
monitoring treatments," said Clifton R. Gaus, Sc.D.,
administrator of AHCPR.
"The problem of non-compliance with prescription medicine
regimens is becoming widely
recognized, thanks in part to NCPIE's efforts to bring the issue
into sharper focus," Dr. Gaus said.
NCPIE estimates that as many as half of all medications are taken
incorrectly, leading each year to
$8.5 billion in unnecessary hospitalization costs, an estimated 9
million adverse drug reactions and
a quarter of all nursing home admissions.
Non-compliance is a problem that affects people of all ages,
occupations, and income and
educational levels, according to NCPIE.
This collaboration was inspired by the inclusion of medications
in many AHCPR-supported
clinical practice guidelines on common medical conditions,
coupled with NCPIE's long-standing
objective of enhancing prescription medicine compliance by
All AHCPR guidelines are accompanied by consumer guides that
to health care practitioners. AHCPR has distributed almost 9
million such guides. This feature of
AHCPR guidelines, unique in the guideline community, was noted by
NCPIE's Chairman, former
Congressman Paul G. Rogers, in making the announcement.
"NCPIE and AHCPR are the right team to help ensure that consumers
receive the information
they need to understand their disease, their diagnosis and the
importance of compliance with their
prescribed medicines," Mr. Rogers said.
"I am certain this is but the first of many collaborations with
AHCPR," he said. "For example, our
national directory of prescription medicine information and
education materials could include
AHCPR-sponsored guidelines that mention prescription drug
NCPIE, established in 1982, is a non-profit coalition of more
than 350 organization—representing
health professionals, consumers, voluntary health agencies,
pharmaceutical research and
manufacturing companies, managed care and government—committed
communication between health care professionals and patients
about prescription medicines.
AHCPR is the lead Federal agency charged with supporting research
designed to improve the
quality of health care, reduce its cost and broaden access to
essential services. AHCPR's broad
programs of research, clinical guideline development and
technology assessment bring practical,
science-based information to health care practitioners and
AHCPR's interest in pharmaceuticals is reflected both in its
guideline program as well as in its
current funding of a number of pharmaceutical outcomes studies
under its Medical Treatment
For additional information, contact AHCPR Public Affairs: Karen Migdail, (301) 427-1855 ; or Salina Prasad, (301) 427-1864; or NCPIE, Erin Hoffman at (202)